We Can Medicines Co., Ltd. (TPEX:6929)
Taiwan · Delayed Price · Currency is TWD 24.60
+0.10 (0.41%)
Jun 18, 2026, 9:05 AM CST
We Can Medicines Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 247.2 | 245.36 | 305.67 | 160.53 | 216.26 | 203.36 |
Trading Asset Securities | - | 40.39 | - | - | - | - |
Cash & Short-Term Investments | 247.2 | 285.75 | 305.67 | 160.53 | 216.26 | 203.36 |
Cash Growth | -6.41% | -6.52% | 90.42% | -25.77% | 6.34% | -24.73% |
Accounts Receivable | 187.96 | 192.69 | 178.05 | 225.54 | 142 | 127.47 |
Other Receivables | 55.86 | 43.19 | 40.75 | 40.05 | 27.98 | 26.08 |
Receivables | 243.82 | 235.89 | 218.8 | 265.59 | 169.98 | 153.55 |
Inventory | 835.08 | 845.97 | 850.88 | 776.83 | 690.45 | 583.97 |
Prepaid Expenses | 41.69 | 80.62 | 87.82 | 87.96 | 75.79 | 52.49 |
Other Current Assets | 0.76 | 1.45 | 1.45 | 0.63 | 2.16 | 1.55 |
Total Current Assets | 1,369 | 1,450 | 1,465 | 1,292 | 1,155 | 994.92 |
Property, Plant & Equipment | 1,453 | 1,473 | 1,562 | 1,515 | 1,370 | 1,150 |
Other Intangible Assets | 4.25 | 4.33 | 6.95 | 3.87 | 4.97 | 9.38 |
Long-Term Deferred Tax Assets | 0.51 | 0.51 | 0.53 | 0.6 | 1.19 | 16.82 |
Other Long-Term Assets | 51.13 | 51.17 | 51.38 | 50.22 | 44.9 | 39.13 |
Total Assets | 2,918 | 2,978 | 3,086 | 2,861 | 2,576 | 2,210 |
Accounts Payable | 479.49 | 512.31 | 507.36 | 540.01 | 517.49 | 443.55 |
Accrued Expenses | 24.14 | 22.91 | 23.02 | 21.46 | 17.35 | 16.66 |
Short-Term Debt | 45 | - | - | 135 | - | - |
Current Portion of Long-Term Debt | 7.34 | 7.3 | 7.14 | 7.07 | 6.25 | - |
Current Portion of Leases | 256.75 | 252.91 | 233.38 | 210.29 | 198.68 | 173.38 |
Current Income Taxes Payable | - | - | - | 4.93 | 5.44 | - |
Current Unearned Revenue | 9.62 | 9.09 | 8.23 | 7.44 | 10.87 | 12.5 |
Other Current Liabilities | 98.14 | 143.34 | 142.25 | 118.9 | 144.27 | 130.02 |
Total Current Liabilities | 920.47 | 947.86 | 921.39 | 1,045 | 900.34 | 776.11 |
Long-Term Debt | 131.48 | 133.33 | 130.63 | 137.71 | 143.75 | 150 |
Long-Term Leases | 790.97 | 803.81 | 870.13 | 826.51 | 708.58 | 567.47 |
Pension & Post-Retirement Benefits | 5.62 | 5.62 | 5.79 | 3.93 | 4.38 | 7.93 |
Other Long-Term Liabilities | 40.3 | 39.16 | 41.5 | 31.26 | 27.09 | 24.17 |
Total Liabilities | 1,889 | 1,930 | 1,969 | 2,045 | 1,784 | 1,526 |
Common Stock | 450.85 | 450.68 | 448.54 | 400 | 400 | 400 |
Additional Paid-In Capital | 670.01 | 669.76 | 664.79 | 353.53 | 343.55 | 339.45 |
Retained Earnings | -82.01 | -72.4 | 1.19 | 62.82 | 48.14 | -54.91 |
Comprehensive Income & Other | -9.87 | 0.41 | 1.65 | - | - | - |
Shareholders' Equity | 1,029 | 1,048 | 1,116 | 816.35 | 791.69 | 684.54 |
Total Liabilities & Equity | 2,918 | 2,978 | 3,086 | 2,861 | 2,576 | 2,210 |
Total Debt | 1,232 | 1,197 | 1,241 | 1,317 | 1,057 | 890.85 |
Net Cash (Debt) | -984.34 | -911.59 | -935.62 | -1,156 | -841 | -687.49 |
Net Cash Per Share | -21.86 | -20.26 | -21.53 | -27.36 | -20.16 | -17.19 |
Filing Date Shares Outstanding | 45.09 | 45.07 | 44.85 | 40 | 40 | 40 |
Total Common Shares Outstanding | 45.09 | 45.07 | 44.85 | 40 | 40 | 40 |
Working Capital | 448.08 | 501.81 | 543.24 | 246.44 | 254.29 | 218.81 |
Book Value Per Share | 22.82 | 23.26 | 24.88 | 20.41 | 19.79 | 17.11 |
Tangible Book Value | 1,025 | 1,044 | 1,109 | 812.48 | 786.72 | 675.16 |
Tangible Book Value Per Share | 22.73 | 23.17 | 24.73 | 20.31 | 19.67 | 16.88 |
Land | 217.03 | 217.03 | 217.03 | 217.03 | 217.03 | 217.03 |
Buildings | 76.49 | 76.49 | 76.49 | 76.49 | 76.49 | 76.49 |
Machinery | 27.64 | 27.19 | 30.02 | 27.62 | 29.14 | 21.67 |
Construction In Progress | 8.14 | 3.62 | 0.68 | 4.4 | 2.49 | 3.5 |
Leasehold Improvements | 376.41 | 376.56 | 387.76 | 345.44 | 304.32 | 232.24 |